National Trust wins Fundraising Campaign of the Year Award
The National Trust’s campaign for Tyntesfield has won the Fundraising Campaign of the Year Award at The UK Charity Awards.
The National Trust’s campaign elicited support from government bodies such as National Heritage Memorial Fund, the Heritage Lottery Fund and the public to raise a remarkable £24m in just 8 weeks to save the Victorian country estate of Tyntesfield near Bristol.
The National Trust announced the emergency campaign in April 2002 to save the Tyntesfield Estate from being sold and broken up. The property in Wraxall, North Somerset, is of unique historical importance and is a complete collection. It consists not only of building and contents, but also extensive financial records, invoices, bills and other paperwork, “providing a unique insight into social history,” according to the Trust.
Advertisement
Tens of thousands of individuals and a number of organisations responded to the campaign. In just 50 days, the campaign’s initial £1 million target was exceeded by half a million pounds raised from more than 50,000 individual donations from across the country. The National Heritage Memorial Fund (NHMF) pledged £17.425m towards the purchase, the largest amount ever awarded by the Fund for a single project.
The campaign involved an appeal to the Trust’s (then) 2.8 million members and thousands of supporters. The campaign received funds from National Trust Centres and Associations, from advertising in the local and national press, leaflet drops, direct mail, online donations and contributions received at National Trust properties and shops. Direct marketing materials for the campaign were prepared by the Blue Frog agency.
The Tyntesfield campaign gained international recognition, with more than 12,000 public donations received from America, Canada, New Zealand, Japan, Australia and Asian countries.
Fundraising still continues in order to secure the long-term future of Tyntesfield.
Finalists in the category included Amnesty International and Marie Curie Cancer Care.